Role of arginine in protein refolding, solubilization, and purification

Biotechnology Progress

Volumn 20, Issue 5, 2004, Pages 1301-1308

  Tsumoto, Kouhei ^a   Umetsu, Mitsuo ^a   Kumagai, Izumi ^a   Ejima, Daisuke ^b   Philo, John S ^c   Arakawa, Tsutomu ^c  

^a TOHOKU UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c ALLIANCE PROTEIN LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DIALYSIS; ESCHERICHIA COLI; PURIFICATION; SOLUBILITY;

DILUTION; FOLDED PROTEINS; PROTEIN AGGREGATION;

PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 5444228298     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0498793     Document Type: Review

References (102)

1. Gribskov, M.; Burgess, R. R. Overexpression and purification of the sigma subunit of Escherichia coli RNA polymerase. Gene 1983, 26, 109-118.
2. Itakura, K.; Hirose, T.; Crea, R.; Riggs, A. D.; Heyneker, H. L.; Boyer, H. W. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 1977, 198, 1056-1063.
3. Georgiou, G.; Telford, J. N.; Shuler, M. L.; Wilson, D. B. Localization of inclusion bodies in Escherichia coli overproducing beta-lactamase or alkaline phosphatase. Appl. Environ. Microbiol. 1986, 52, 1157-1161.
4. Bowden, G. A.; Paredes, A. M.; Georgiou, G. Structure and morphology of protein inclusion bodies in Escherichia coli. Biotechnology 1990, 9, 725-730.
5. Fink, A. L. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Folding Des. 1998, 3, R9-R23.
6. Villaverde, A.; Carrio, M. M. Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol. Lett. 2003, 25, 1385-1395.
7. Carrio, M. M.; Cubarsi, R.; Villaverde, A. Fine architecture of bacterial inclusion bodies. FEBS Lett. 2000, 537, 215-221.
8. Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10, 524-530.
9. Rudolph, R.; Lilie, H. In vitro folding of inclusion body proteins. FASEB J. 1996, 10, 49-56.
10. Misawa, S.; Kumagai, I. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies. Biopolymers 1999, 51, 297-307.
11. Tsumoto, K.; Ejima, D.; Kumagai, I.; Arakawa, T. Practical considerations in refolding proteins from inclusion bodies. Protein Expression Purif. 2003, 28, 1-8.
12. Clark, E. D. B. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 1998, 9, 157-163.
13. Buchner, J.; Rudolph, R. Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology 1991, 9, 157-162.
14. Brinkmann, U.; Buchner, J.; Pastan, I. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3075-3079.
15. Rudolph, R.; Boehn, G.; Lilie, H.; Jaenicke, R. Folding proteins. In A Practical Approach in Protein Function, 2nd ed.; Creighton, T. E., Ed.; IRL Press: Oxford, 1997; pp 57-99.
16. Arora, D.; Khanna, N. J. Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies. J. Biotechnol. 1996, 52, 127-133.
17. Tsumoto, K.; Shinoki, K.; Kondo, H.; Uchikawa, M.; Juji, T.; Kumagai, I. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent - application to a human single-chain Fv fragment. J. Immunol. Methods 1998, 219, 119-129.
18. Umetsu, M.; Tsumoto, K.; Hara, M.; Ashish, K.; Goda, S.; Adschiri, T.; Kumagai, I. How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J. Biol. Chem. 2003, 279, 8979-8987.
19. Rudolph, R.; Opits, U.; Hesse, F.; Riebland, R.; Fischer, S. Reactivation of microbially produce human tissue-type plasminogen activator. In Biotechnology International; North, K., Ed.; Century Press: London, 1992; pp 321-325.
20. Bell, S.; Hansen, S.; Buchner, J. Refolding and structural characterization of the human p53 tumor suppressor protein. Biophys. Chem. 2002, 96, 243-257.
21. Lin, W. J.; Traugh, J. A. Renaturation of casein kinase II from recombinant subunits produced in Escherichia coli: purification and characterization of the reconstituted holoenzyme. Protein Expression Purif. 1993, 4, 256-264.
22. Hsih, M. H.; Kuo, J. C.; Tsai, H. J. Optimization of the solubilization and renaturation of fish growth hormone produced by Escherichia coli. Appl. Microbiol. Biotechnol. 1997, 48, 66-72.
23. Clark, E. D. B.; Schwarz, E.; Rudolph, R. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol. 1999, 309, 217-237.
24. Hevehan, D. L.; Clark, E. D. B. Oxidative renaturation of lysozyme at high concentrations. Biotechnol. Bioeng. 1997, 54, 221-230.
25. Nozaki, Y.; Tanford, C. The solubility of amino acids and related compounds in aqueous urea solutions. J. Biol. Chem. 1963, 245, 4074-4081
26. Nozaki, Y.; Tanford, C. The solubility of amino acids, diglycine, and triglycine in aqueous guanidine hydrochloride solutions. J. Biol. Chem. 1970, 245, 1648-1652
27. Kita, Y.; Arakawa, T.; Lin, T. Y.; Timasheff, S. N. Contribution of the surface free energy perturbation to protein-solvent interactions. Biochemistry 1994, 33, 15178-15189.
28. Arakawa, T.; Timasheff, S. N. Stabilization of protein structure by sugars. Biochemistry 1982, 21, 6536-6544.
29. Gekko, K.; Timasheff, S. N. Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 1981, 20, 4667-4676.
30. Arakawa, T.; Timasheff, S. N. Preferential interactions of proteins with solvent components in aqueous amino acid solutions. Arch. Biochem. Biophys. 1983, 224, 169-177.
31. Arakawa, T.; Timasheff, S. N. Protein stabilization and destabilization by guanidinium salts. Biochemistry 1984, 23, 5924-5929.
32. Arakawa, T.; Timasheff, S. N. The stabilization of proteins by osmolytes. Biophys. J. 1985, 47, 411-414.
33. Arakawa, T.; Bhat, R.; Timasheff, S. N. Why preferential hydration does not always stabilize the native structure of globular proteins. Biochemistry 1990, 29, 1924-1931.
34. Curtis, R. A.; Ulrich, J.; Montaser, A.; Prausnitz, J. M.; Blanch, H. W. Protein-protein interactions in concentrated electrolyte solutions. Biotechnol. Bioeng. 2002, 79, 367-380.
35. Melander, W.; Horvath, C. Salt effect on hydrophobic interactions in precipitation and chromatography of proteins: an interpretation of the lyotropic series. Arch. Biochem. Biophys. 1977, 183, 200-215.
36. Washabaugh, M. W.; Collins, K. D. The systematic characterization by aqueous column chromatography of solutes which affect protein stability. J. Biol. Chem. 1986, 261, 12477-12485.
37. Makrides, S. C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 1996, 60, 512-538.
38. Rosenfeld, R. D.; Zeni, L.; Welcher, A. A.; Narhi, L. O.; Hale, C.; Marasco, J.; Delaney, J.; Gleason, T.; Philo, J. S.; Katta, V.; Hui, J.; Baumgartner, J.; Graham, M.; Stark, K. L.; Karbon, W. Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry 1998, 37, 16041-16052.
39. Rinas, U.; Risse, B.; Jaenicke, R.; Abel., K. J.; Zettlmeissl., G. Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein. Biol. Chem. Hoppe-Seyler 1990, 371, 49-56
40. Ahn, J. H.; Lee, Y. P.; Rhee, J. S. Investigation of refolding condition for Pseudomonas fluorescens lipase by response surface methodology. J. Biotechnol. 1997, 54, 151-160.
41. Buchner, J.; Pastan, I.; Brinkmann, U. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 1992, 205, 263-270.
42. Das, D.; Kriangkum, J.; Nagata, L. P.; Fulton, R. E.; Suresh, M. R.Development of a biotin mimic tagged ScFv antibody against western equine encephalitis virus: bacterial expression and refolding. J. Virol. Methods 2004, 117, 169-177.
43. Wright, E.; Serpersu, E. H. Isolation of aminoglycoside nucleotidyltransferase (2″)-Ia from inclusion bodies as active, monomeric enzyme. Protein Expression Purif. 2004 35, 373-380.
44. Urieto, J. O.; Liu, T.; Black, J. H.; Cohen, K. A.; Hall, P. D.; Willingham, M. C.; Pennell, L. K.; Hogge, D. E.; Kreitman, R. J.; Frankel, A. E. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials. Protein Expression Purif. 2004, 33, 123-133.
45. Menzella, H. G.; Gramajo, H. C.; Ceccarelli, E. A. High recovery of prochymosin from inclusion bodies using controlled air oxidation. Protein Expression. Purif. 2002, 25, 248-255.
46. Soejima, K.; Mimura, N.; Yonemura, H.; Nakatake, H.; Imamura, T.; Nozaki, C. An efficient refolding method for the preparation of recombinant human prethrombin-2 and characterization of the recombinant-derived alpha-thrombin. J. Biochem. 2001, 130, 269-277.
47. Takemura, S.; Asano, R.; Tsumoto, K.; Ebara, S.; Sakurai, N.; Katayose, Y.; Kodama, H.; Yoshida, H.; Suzuki, M.; Imai, K.; Matsuno, S.; Kudo, T.; Kumagai, I. Construction of a diabody (small recombinant bispecific antibody) using a refolding system. Protein Eng. 2000, 13, 583-588.
48. Asano, R.; Kudo, T.; Nishimura, Y.; Makabe, K.; Hayashi, H.; Suzuki, M.; Tsumoto, K.; Kumagai, I. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment. J. Biochem. 2002, 132, 903-909.
49. Asano, R.; Kudo, T.; Makabe, K.; Tsumoto, K.; Kumagai, I. Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli. FEBS Lett. 2002, 528, 70-76.
50. Schaffner, J.; Winter, J.; Rudolph, R.; Schwarz, E. Cosecretion of chaperones and low-molecular-size medium additives increases the yield of recombinant disulfide-bridged proteins. Appl. Environ. Microbiol. 2001, 76, 3994-4000.
51. Denefle, P.; Kovarik, S.; Ciora, T.; Gosselet, N.; Benichou, J.-C.; Latta, M.; Guinet, F.; Ryter, A.; Mayaux, J.-F. Heterologous protein export in Escherichia coli: influence of bacterial signal peptides on the export of human interleukin 1 beta. Gene 1989, 85, 499-510.
52. Jung, G.; Denefle, P.; Becquart, J.; Mayaux, J.-F. High-cell density fermentation studies of recombinant Escherichia coli strains expressing human interleukin-1 beta. Ann. Inst. Pasteur Microbiol. 1988, 139, 129-146.
53. Hart, R. A.; Rinas, U.; Bailey, J. E. Protein composition of Vitreoscilla hemoglobin inclusion bodies produced in Escherichia coli. J. Biol. Chem. 1990, 265, 12728-12733.
54. Wulfing, C.; Plueckthun, A. Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts. J. Mol. Biol. 1994, 242, 655-669.
55. Schein, C. H. Solubility as a function of protein structure and solvent components. Biotechnology 1989, 7, 1141-1149.
56. Sawyer, J. R.; Schlom, J.; Kashmiri, S. V. The effects of induction conditions on production of a soluble antitumor sFv in Escherichia coli. Protein Eng. 1994, 7, 1401-1406.
57. Proudfoot, A. E.; Goffin, L.; Payton, M. A.; Wells, T. N.; Bernard, A. R. In vivo and in vitro folding of a recombinant metalloenzyme, phosphomannose isomerase. Biochem. J. 1996, 318, 437-442.
58. Caspers, P.; Stieger, M.; Burn, P. Overproduction of bacterial chaperones improves the solubility of recombinant protein tyrosine kinases in Escherichia coli. Cell. Mol. Biol. 1994, 40, 635-644.
59. Yasukawa, T.; Kanei-Ishii, C.; Maekawa, T.; Fujimoto, J.; Yamamoto, T.; Ishii, S. Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J. Biol. Chem. 1995, 270, 25328-25331.
60. Clement, J. M.; Jehanno. M.; Popescu, O.; Saurin, W.; Hofnung, M. Expression and biological activity of genetic fusions between MalE, the maltose binding protein from Escherichia coli and portions of CD4, the T-cell receptor of the AIDS virus. Protein Expression Purif. 1996, 8, 319-331.
61. Kapust, R. B.; Waugh, D. S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 1999, 8, 1668-1674.
62. Tsumoto, K.; Umetsu, M.; Kumagai, I.; Ejima, D.; Arakawa, T. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem. Biophys. Res. Commun. 2003, 312, 1383-1386.
63. Oberg, K.; Chrunyk, B. A.; Wetzel, R.; Fink, A. L. Native-like secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR. Biochemistry 1994, 33, 2628-34.
64. Georgiou, G.; Valax, P. Expression of correctly folded proteins in Escherichia coli. Curr. Opin. Biotechnol. 1996, 7, 524-526.
65. Fukuda, H.; Arai, M.; Kuwajima, K. Folding of green fluorescent protein and the cycle3 mutant. Biochemistry 2000, 39, 12025-12032.
66. Umetsu, M.; Tsumoto, K.; Ashish, K.; Nitta, S.; Tanaka, Y.; Adschiri, T.; Kumagai, I. Structural characteristics and refolding of in vivo aggregated hyperthermophilic archaeon proteins. FEBS Lett. 2004, 557, 49-56.
67. Antibodies: A Laboratory Manual; Harlow, E., Lane, D., Eds.; Cold Spring Harbor Laboratory Press: Woodbury, NY, 1988.
68. Fahrmer, R. L.; Whitney, D. H.; Vandertaan, M.; Blank, G. Biotechnol. Appl. Biochem. 1999, 30, 121-128.
69. Hahn, R.; Schlegel, R.; Jungbauer, A. Comparison of protein A affinity sorbents. J. Chromotogr. B 2003, 790, 35-51.
70. Sarciaux, J. M.; Mansour, S.; Hageman, M. J.; Nail, S. L. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. J. Pharm. Sci. 1999, 88, 1354-1361.
71. Paborji, M.; Pochopin, N. L.; Coppola, W. P.; Bogardus, J. B. Chemical and physical stability of chimeric L6, a mouse-human monoclonal antibody. Pharm. Res. 1994, 11, 764-771.
72. Buchner, J.; Renner, M. R.; Lilie, H.; Hinz, H.-J.; Jaenicke, R.; Kiefhaber, T.; Rudolph, R. Alternatively folded states of an immunoglobulin. Biochemistry 1991, 30, 6922-6929.
73. Vermeer, A. W. P.; Norde, W. The thermal stability of immunoglobulin: unfolding and aggregation of a multidomain protein. Biophys. J. 2000, 78, 394-404.
74. Welfle, K.; Misselwitz, R.; Hausdorf, G.; Hohne, W.; Welfle, H. Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments. Biochim. Biophys. Acta 1999, 1431, 120-131.
75. Arakawa, T.; Philo, J. S.; Tsumoto, K.; Yumioka, R.; Ejima, D. Elution of antibodies from a Protein-A column by aqueous arginine solutions. Protein Expression Purif. 2004, 36, 244-248.
76. Horan, T. P.; Martin, F.; Simonet, L.; Arakawa, T.; Philo, J. S. Dimerization of granulocyte-colony stimulating factor receptor: the Ig plus CRH construct of granulocyte-colony stimulating factor receptor forms a 2:2 complex with a ligand. J. Biochem. 1997, 121, 370-375.
77. Arakawa, T.; Dix, D. B.; Chang, B. S. The effects of protein stabilizers on aggregation induced by multiple-stresses. Yakugaku Zasshi 2003, 123, 95-961.
78. Hsu, C. C.; Nguyen, H. M.; Yeung, D. A.; Brooks, D. A.; Koe, G. S.; Bewley, T. A.; Pearlman, R. Surface denaturation at solid-void interface - a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharm. Res. 1995, 12, 69-77.
79. Arakawa, T.; Tsumoto, K. The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun. 2003, 304, 148-152.
80. Shiraki, K.; Kudou, M.; Fujiwara, S.; Imanaka, T.; Takagi, M. Biophysical effect of amino acids on the prevention of protein aggregation. J. Biochem. 2002, 132, 591-595.
81. Tang, L. H.; Powell, D. R.; Escott, B. M.; Adams, E. T., Jr. Analysis of various indefinite self-associations. Biophys. Chem. 1977, 7, 121-139.
82. Tessier, P. M.; Lenhoff, A. M. Measurements of protein self-association as a guide to crystallization. Curr. Opin. Biotechnol. 2003, 14, 512-516.
83. Garcia, C. D.; Hadley, D. J.; Wilson, W. W.; Henry, C. S. Measuring protein interactions by microchip self-interaction chromatography. Biotechnol. Prog. 2003, 19, 1006-1010.
84. Ho, J. G. S.; Middleberg, A. P. J.; Ramage, P.; Kocher, H. P. The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient. Protein Sci. 2003, 12, 708-716.
85. Hofmeister, F. Zur lehre von der Wirkung der saltze. Arch. Exp. Pathol. Pharmakol. 1888, 24, 247-260.
86. Collins, K. D.; Washabaugh, M. W. The Hofmeister effect and the behaviour of water at interfaces. Q. Rev. Biophys. 1985, 18, 323-422.
87. Traube, J. The attraction pressure. J. Phys. Chem. 1910, 14, 452-470.
88. Arakawa, T.; Timasheff, S. N., Mechanism of protein salting in and salting out by divalent cation salts: balance between hydration and salt binding. Biochemistry 1984, 23, 5912-5923
89. Futaki, S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 2002, 245, 1-7.
90. Umezawa, N.; Gelman, M. A.; Haigis, M. C.; Raines, R. T.; Gellman, S. H. Translocation of a beta-peptide across cell membranes. J. Am. Chem. Soc. 2002, 124, 368-369.
91. Calnan, B. J.; Tidor, B.; Biancalana, S.; Hudson, D.; Frankel, A. D. Arginine-mediated RNA recognition: the arginine fork. Science 1991, 252, 1167-1171.
92. Flocco, M. M.; Mowbray, S. L. Planar stacking interactions of arginine and aromatic side-chains in proteins. J. Mol. Biol. 1994, 235, 709-717.
93. Mitchell, J. B. O.; Nandi, C. L.; McDonald, I. K.; Thornton, J. M.; Price, S. L. Amino/aromatic interactions in proteins: is the evidence stacked against hydrogen bonding? J. Mol. Biol. 1994, 239, 315-331.
94. Pellequer, J.-L.; Zhao, B.; Kao, H.-I.; Bell, C. W.; Li, K.; Li, Q. L.; Karu, A. E.; Oberts, V. A. Stabilization of bound polycyclic aromatic hydrocarbons by a pi-cation interaction. J. Mol. Biol. 2000, 302, 691-699.
95. Tanaka, Y.; Tsumoto, K.; Umetsu, M.; Tanaka, I.; Arakawa, T.; Kumagai, I. Structural evidence for guanidine-protein side chain interactions: Crystal structure of CutA from Pyrococcus horikoshii in 3 M guanidine hydrochloride. Biochem. Biophys. Res. Commun. 2004, in press.
96. Burley, S. K.; Petsko, G. A. Amino-aromatic interactions in proteins. FEBS Lett. 1986, 203, 139-143.
97. Dougherty, D. A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 1996, 271, 163-168.
98. Zacharias N.; Dougherty, D. A. Cation-pi interactions in ligand recognition and catalysis. Trends Pharmacol. Sci. 2002, 23, 281-287.
99. von Hippel, P. H.; Wong, K-Y. The effect of ions on the kinetics of formation and the stability of the collagenfold. Biochemistry 1962, 1, 664-674.
100. von Hippel, P. H.; Wong, K-Y. On the conformational stability of globular proteins. The effects of various electrolytes and nonelectrolytes on the thermal ribonuclease transition. J. Biol. Chem. 1965, 240, 3909-3923.
101. Tanford, C. Protein denaturation. Adv. Protein Chem. 1968, 23, 122-282.
102. Tanford, C. Protein denaturation. C. Theoretical models for the mechanism of denaturation. Adv. Protein Chem. 1970, 24, 1-95.